Is Astal Laboratories Ltd debt-free?

Yes, Astal Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.37.

Home

Astal Laboratories Ltd

Astal Laboratories Ltd Financials

Astal Laboratories Ltd Financial Statement

Astal Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Jun 2025	Mar 2025	Dec 2024
Revenue	25.38	23.50	14.51
Operating Expense	22.17	19.28	11.13
Net Profit	2.09	2.74	2.49
Net Profit Margin	8.23	11.66	17.16
Earning Per Share	2.13	2.80	2.53
EBIDTA	2.97	4.22	3.28
Effective Tax Rate	14.33	26.30	12.72

Particulars	Jun 2025
Revenue	25.38
Operating Expense	22.17
Net Profit	2.09
Net Profit Margin	8.23
Earning Per Share	2.13
EBIDTA	2.97
Effective Tax Rate	14.33

Astal Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	64.23	23.65	3.43
Operating Expenses Annual	51.45	22.53	3.57
Operating Profit Annual	12.90	1.13	0.04
Interest Annual	0.70	0.01	TBA
Depreciation	0.22	0.03	0.01
Net Profit Annual	8.93	0.78	0.02
Tax Annual	3.05	0.30	0.02

Particulars	Mar 2025
Total Revenue Annual	64.23
Operating Expenses Annual	51.45
Operating Profit Annual	12.90
Interest Annual	0.70
Depreciation	0.22
Net Profit Annual	8.93
Tax Annual	3.05

Astal Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	6.08	0.08	0.02
Cash Flow from Operations	-12.52	-5.58	-1.44
Cash Flow from Investing	-7.81	-6.11	1.50
Cash Flow from Financing	3.29	17.68	TBA
Cash Flow at the End	-10.96	6.08	0.08

Particulars	Mar 2025
Cash Flow at the Beginning	6.08
Cash Flow from Operations	-12.52
Cash Flow from Investing	-7.81
Cash Flow from Financing	3.29
Cash Flow at the End	-10.96

Astal Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	20.08	4.78	1.17
PBIT Margin (%)	19.74	4.65	0.87
PBT Margin (%)	-8.46	-456.24	0.87
Net PROFIT Margin (%)	13.90	3.30	0.58
Return On Networth / Equity (%)	30.10	5.47	0.39
Return On Networth /Employed (%)	34.78	7.56	0.77
Return On Assets (%)	24.47	5.41	0.38
Total Debt / Equity (X)	0.23	0.01	TBA
Asset Turnover Ratio (%)	1.76	1.64	0.66

Particulars	Mar 2025
PBDIT Margin (%)	20.08
PBIT Margin (%)	19.74
PBT Margin (%)	-8.46
Net PROFIT Margin (%)	13.90
Return On Networth / Equity (%)	30.10
Return On Networth /Employed (%)	34.78
Return On Assets (%)	24.47
Total Debt / Equity (X)	0.23
Asset Turnover Ratio (%)	1.76

Astal Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	11.44	0.69	0.01
Total Current Assets Annual	45.64	26.73	6.11
Non Current Assets Annual	17.70	9.89	3.79
Total Shareholders Funds Annual	35.99	23.34	5.18
Total Assets Annual	63.34	36.61	9.91

Particulars	Mar 2025
Fixed Assets Annual	11.44
Total Current Assets Annual	45.64
Non Current Assets Annual	17.70
Total Shareholders Funds Annual	35.99
Total Assets Annual	63.34

Astal Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Astal Laboratories Ltd Financials

As of Sep 27, 2025, Astal Laboratories Ltd has a market capitalization of 134.08 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Astal Laboratories Ltd is with a debt-to-equity ratio of 0.37.

In FY 2024 , Astal Laboratories Ltd recorded a total revenue of approximately 64.23 Cr marking a significant milestone in the company's financial performance.

Astal Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 1.2% and 1.5% annually, respectively..

Astal Laboratories Ltd's current PE ratio is 15.01.

Astal Laboratories Ltd's ROCE averaged 10.3% from the FY ending March 2023 to 2025, with a median of 4.6%. It peaked at 25.7% in March 2025, reflecting strong capital efficiency over the period..

Astal Laboratories Ltd's latest EBIT is Rs. 12.68 Cr, surpassing the average EBIT of Rs. 4.60 Cr over the 5 years..